Schedule 13D ownership disclosure

AEROVATE THERAPEUTICS INC

Security class unavailable · CUSIP: 008064107

Event date: 2022-07-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,327,909
Percent of class
9.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-22-007804
Form type
SC 13D/A
Filer
Jade Biosciences, Inc.
CIK
CIK 1798749
Filed
Jul 20, 2022
Reporting period
Jul 15, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub